Proton Pump Inhibitors
-
Subject Areas on Research
- A Population-Based Pharmacokinetic Model Approach to Pantoprazole Dosing for Obese Children and Adolescents.
- A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors.
- A relic or still relevant: the narrowing role for vagotomy in the treatment of peptic ulcer disease.
- Acidity of Enteral Feeding Tube Aspirate in Neonates: Do pH Values Meet the Cutoff for Predicting Gastric Placement?
- Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.
- Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.
- Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.
- Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy.
- Artificial intelligence automates and augments baseline impedance measurements from pH-impedance studies in gastroesophageal reflux disease.
- Association of CYP2C19 polymorphisms and lansoprazole-associated respiratory adverse effects in children.
- Associations between Community-Acquired Pneumonia and Proton Pump Inhibitors in the Laryngeal/Voice-Disordered Population.
- Associations between Community-Acquired Pneumonia and Proton Pump Inhibitors in the Laryngeal/Voice-Disordered Population.
- Bariatric Embolization: Pilot Study on the Impact of Gastroprotective Agents and Arterial Distribution on Ulceration Risk and Efficacy in a Porcine Model.
- Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease.
- Chronic hypergastrinemia: causes and consequences.
- Clinical outcomes in patients with the concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention: an analysis from the Guthrie Health Off-Label Stent (GHOST) investigators.
- Clinical practice guideline: hoarseness (dysphonia).
- Clopidogrel and PPI interaction: clinically relevant or not?
- Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations.
- Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial.
- Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes.
- Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.
- Does acid suppressive therapy reduce the risk of laryngeal cancer recurrence?
- Dysphagia in a 34-Year-Old Woman.
- Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease.
- Efficacy of esomeprazole for treatment of poorly controlled asthma.
- Eradicating Multi-Drug-Resistant Helicobacter pylori with Four Times Daily Lansoprazole.
- Etiology and complications of thrombocytopenia in hospitalized medical patients.
- GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
- Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
- Genotype tailored treatment of mild symptomatic acid reflux in children with uncontrolled asthma (GenARA): Rationale and methods.
- High economic burden of caring for patients with suspected extraesophageal reflux.
- Hypoxic cell death is reduced by pH buffering in a model of engineered heart tissue.
- Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
- Impact of Adjuvant Medical Therapies on Surgical Outcomes in Idiopathic Subglottic Stenosis.
- Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
- Impact of second-generation transoral incisionless fundoplication on atypical GERD symptoms: a systematic review and meta-analysis.
- Indications for the Use of Proton Pump Inhibitors for Stress Ulcer Prophylaxis and Peptic Ulcer Bleeding in Hospitalized Patients.
- Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review.
- Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.
- Long-Term Quality of Life Outcomes Following Nissen Versus Toupet Fundoplication in Patients with Gastroesophageal Reflux Disease.
- Mean Nocturnal Baseline Impedance Correlates With Symptom Outcome When Acid Exposure Time Is Inconclusive on Esophageal Reflux Monitoring.
- Medical and nutrition management of eosinophilic esophagitis in children.
- Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates.
- Non-acid Reflux: What to Do When You Don't Feel the Burn.
- Obese Children Require Lower Doses of Pantoprazole Than Nonobese Peers to Achieve Equal Systemic Drug Exposures.
- Obesity in children with poorly controlled asthma: Sex differences.
- Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.
- Omeprozole therapy in pediatric patients after liver and intestinal transplantation.
- Osteoporosis piece of multi-morbidity puzzle in geriatric care.
- Outcomes associated with proton pump inhibitors and distal radius fractures: A post-hoc comparative analysis.
- PA tablets: investigational compounds combining aspirin and omeprazole for cardioprotection.
- Pharmacodynamic effects of cilostazol versus clopidogrel in stented patients under proton pump inhibitor co-administration: the ACCEL-PARAZOL study.
- Pharmacologic management of voice disorders by general medicine providers and otolaryngologists.
- Platelet activity associated with concomitant use of clopidogrel and proton pump inhibitors in children with cardiovascular disease.
- Prescribing patterns of primary care physicians and otolaryngologists in the management of laryngeal disorders.
- Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring.
- Proton Pump Inhibitor Prescribing and Monitoring Patterns Among Gastroenterology Practitioners.
- Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.
- Proton Pump Inhibitors vs Histamine-2 Receptor Blockers for Stress Ulcer Prophylaxis in Critically Ill Patients: Issues of Interpretability in Pragmatic Trials.
- Proton pump inhibitor usage reduces sustained viral response rates for veterans with HIV/HCV coinfection on ledipasvir/sofosbuvir: a real-world study from a multicentre VA cohort.
- Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort.
- Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm?
- Proton pump inhibitors and hypomagnesemia in patients with arrhythmias.
- Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.
- Proton-pump inhibitor use is not associated with severe COVID-19-related outcomes: a propensity score-weighted analysis of a national veteran cohort.
- Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn.
- Reducing Overuse of Proton Pump Inhibitors for Stress Ulcer Prophylaxis and Nonvariceal Gastrointestinal Bleeding in the Hospital: A Narrative Review and Implementation Guide.
- Review of pharmacokinetic and pharmacodynamic modeling and safety of proton pump inhibitors and aspirin.
- The drug-drug interaction between proton pump inhibitors and clopidogrel.
- The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin.
- Three year's experience with the Stretta procedure: did it really make a difference?
- Weight Gain in Zollinger-Ellison Syndrome After Acid Suppression.
-
Keywords of People
- Cohen, Seth Morris, Professor of Head and Neck Surgery & Communication Sciences, Head and Neck Surgery & Communication Sciences